Modelling of Human Neurodegenerative Diseases using iPSCs and Genetically Modified Non-Human Primates.

2:00 pm on Wednesday, October 16, 2019
3:20 pm on Wednesday, October 16, 2019
Contact Name:
Licia Holman
To investigate the pathogenic mechanisms and develop new interventions for these the major neurodegenerative diseases, such as Alzheimer Disease (AD), PD and ALS, we took advantage of induced pluripotent stem cells (iPSCs) technologies and Genetically Modified (GM) non-human primates for modelling human neurological disorders.